Considering that the eGFRcr slope was not different to the eGFRcys slope in predicting CKD progression in our study, the use of creatinine level should be considered more cost effective than that of cystatin C level when tracking the renal function in patients with CKD. The gene discussed is CST3; the disease is chronic kidney disease.